Literature DB >> 6892569

Expression of a variant form of actin and additional polypeptide changes following chemical-induced in vitro neoplastic transformation of human fibroblasts.

J Leavitt, T Kakunaga.   

Abstract

Malignant human fibroblasts, transformed in vitro by a single chemical treatment, and the untransformed parental cells have been compared by two-dimensional gel electrophoresis of their proteins. One transformed cell line, HUT-14, exhibits an abundance of a new polypeptide, A' (pI 5.2; molecular weight 44,000), amounting to approximately 3% of the cellular protein. There are at least 23 additional differences in polypeptides out of greater than 1000 electrophoretically distinguishable species. The A' polypeptide has been identified as a variant form of actin by immunoprecipitation with anti-actin antibody and comparison of its tryptic peptide patterns with those produced by beta- and gamma-actin polypeptides also found in HUT-14 cells. A' is distinguishable from the normal forms of actin (alpha, beta, and gamma polypeptides) in that it is more acidic and migrates at a slower rate in sodium dodecyl sulfate gels. Synthesis of A' may occur as a result of a somatic mutation affecting one of the normal actin genes. The electrophoretic behavior of A' in two-dimensional gels is compatible with several mutation models.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6892569

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Correction of the N-terminal sequences of the human plastin isoforms by using anchored polymerase chain reaction: identification of a potential calcium-binding domain.

Authors:  C S Lin; R H Aebersold; J Leavitt
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

2.  Identification and order of sequential mutations in beta-actin genes isolated from increasingly tumorigenic human fibroblast strains.

Authors:  C S Lin; S Y Ng; P Gunning; L Kedes; J Leavitt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

3.  Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns.

Authors:  S Nakajima-Iijima; H Hamada; P Reddy; T Kakunaga
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

4.  A human beta-actin expression vector system directs high-level accumulation of antisense transcripts.

Authors:  P Gunning; J Leavitt; G Muscat; S Y Ng; L Kedes
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

5.  Cloning and characterization of a cDNA encoding transformation-sensitive tropomyosin isoform 3 from tumorigenic human fibroblasts.

Authors:  C S Lin; J Leavitt
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

6.  Expression of transfected mutant beta-actin genes: alterations of cell morphology and evidence for autoregulation in actin pools.

Authors:  J Leavitt; S Y Ng; U Aebi; M Varma; G Latter; S Burbeck; L Kedes; P Gunning
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

7.  Expression of transfected mutant beta-actin genes: transitions toward the stable tumorigenic state.

Authors:  J Leavitt; S Y Ng; M Varma; G Latter; S Burbeck; P Gunning; L Kedes
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

8.  Tropomyosin isoform switching in tumorigenic human fibroblasts.

Authors:  J Leavitt; G Latter; L Lutomski; D Goldstein; S Burbeck
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

9.  Genetic analysis of human lymphocyte proteins by two-dimensional gel electrophoresis: 3. Frequent occurrence of genetic variants in some abundant polypeptides of PHA-stimulated peripheral blood lymphocytes.

Authors:  H Hamaguchi; M Yamada; M Shibasaki; R Mukai; T Yabe; I Kondo
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

10.  Actin and tubulin of normal and leukaemic lymphocytes.

Authors:  H Atkins; P J Anderson
Journal:  Biochem J       Date:  1982-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.